1. Home
  2. PRTA

as 04-11-2025 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
+
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
+
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

;SMA (50)$13.51EMA (200)$17.43O: $9.69 H: $10.25 L: $9.59 C: $10.22 +0.53 (+5.47%)Elder Ray −1.25, −1.91
Founded: 2012 Country:
Ireland
Ireland
Employees: N/A City: DUBLIN 2
Market Cap: 809.8M IPO Year: N/A
Target Price: $54.57 AVG Volume (30 days): 562.6K
Analyst Decision: Buy Number of Analysts: 9
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.27 EPS Growth: N/A
52 Week Low/High: $9.30 - $25.42 Next Earning Date: 05-07-2025
Revenue: $135,157,000 Revenue Growth: 47.92%
Revenue Growth (this year): -62.18% Revenue Growth (next year): 131.73%

PRTA Daily Stock ML Predictions

SELLHOLDBUYas of 13 hours ago

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use